文献速递类风湿关节炎

同型瓜氨酸化肽在人源化类风湿关节炎小鼠模型中驱动促炎性T细胞反应

Homocitrullinated Peptides Drive Pro-Inflammatory T Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2026-06-08

该研究在人源化HLA-DRB1*04转基因(DR4tg)小鼠中皮下注射同型瓜氨酸化肽HomoCitJED,10天后检测引流淋巴结和脾脏T细胞表型、细胞因子与增殖能力。结果显示HomoCitJED诱导Th1、Th17及混合Th1/Th17显著扩增,并伴CD8+ T细胞活化与耗竭标志物升高,提示同型瓜氨酸驱动T细胞失衡可能参与RA发病。

要点

  • HomoCitJED免疫使引流淋巴结Th1、Th17及混合Th1/Th17细胞增加逾七倍。
  • CD4+与CD8+ T细胞均表现活化与耗竭标志物(LAG-3、Tim-3、KLRG1)升高。
  • 同型瓜氨酸驱动的T细胞失衡或为RA发病机制及免疫调节治疗的潜在靶点。

核心结论

  • 同型瓜氨酸化肽可诱导Th1/Th17与Tc1/Tc17反应,并伴活化与耗竭标志物共表达,符合失调状态。
  • 同型瓜氨酸驱动的CD4+和CD8+ T细胞失衡可能是RA发病的机制之一,并可作为未来免疫调节治疗的靶点。

研究设计与样本

  • 研究采用人源化HLA-DRB1*04转基因(DR4tg)类风湿关节炎小鼠模型,该模型表达该病最强的遗传风险因素。
  • DR4tg小鼠(n = 6-15)皮下注射同型瓜氨酸化肽HomoCitJED,对照小鼠注射磷酸盐缓冲液。
  • 10天后通过流式细胞术、酶联免疫吸附试验和ProQuantum免疫分析检测引流淋巴结和脾脏T细胞的表型、细胞因子产生和增殖能力。

主要发现

  • 与对照相比,HomoCitJED免疫驱动引流淋巴结中T辅助细胞亚群显著扩增,Th1、Th17和混合Th1/Th17细胞增加逾七倍(P < 0.0087)。
  • 细胞因子染色证实效应活性,IL-17A+、TNF-α+IL-17A+和IFN-γ+IL-17A+细胞频率升高(P < 0.0207)。
  • 耗竭相关标志物升高,包括LAG-3+和Tim-3+ CD4+ T细胞(P < 0.0411)。
  • CD8+ T细胞呈相似改变,CD25增加六倍、KLRG1表达加倍,伴IL-17A及IFN-γ/IL-17A产生增加和抗原特异性增殖(P < 0.0379)。
  • CD8+ T细胞上耗竭相关标志物Tim-3+和LAG-3+表达亦升高(P < 0.0205)。

临床怎么用

  • 结果支持将同型瓜氨酸化肽驱动的CD4+与CD8+ T细胞失衡视为RA的潜在机制,为未来免疫调节治疗提供靶点方向。
  • 抗同型瓜氨酸化蛋白/肽抗体对RA具有特异性并预示较差预后,提示对同型瓜氨酸化肽的自身反应性可能具致病作用。

局限性

  • 研究基于DR4tg小鼠模型,样本量为每组n = 6-15,结论向人类RA的外推需进一步验证。
  • 摘要未报告对HomoCitP特异性T细胞反应在人类中的直接验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anti-homocitrullinated protein/peptide antibodies are specific to rheumatoid arthritis (RA) and predictive of worse prognosis, suggesting a pathogenic role for autoreactivity to homocitrullinated peptides (HomoCitP). However, T cell responses to HomoCitP remain largely unexplored. We investigated these responses in a humanized HLA-DRB1*04-transgenic (DR4tg) mouse model of RA, which expresses the strongest genetic risk factor for this disease. METHODS: DR4tg mice (n = 6-15) were injected subcutaneously with a HomoCitP called HomoCitJED, whereas control mice received phosphate-buffered saline. After 10 days, T cells were analyzed for their phenotypic characteristics, cytokine production, and proliferative capacities in draining lymph nodes (dLNs) and spleens by flow cytometry, enzyme-linked immunosorbent assays, and ProQuantum immunoassays. RESULTS: HomoCitJED immunization, compared with controls, drove robust expansion of T helper subsets in the dLNs, including more than a seven-fold increase in Th1, Th17, and hybrid Th1/Th17 cells (P < 0.0087). Cytokine staining confirmed effector activity, with higher frequencies of IL-17A+, TNF-α+IL-17A+, and IFN-γ+IL-17A+ cells (P < 0.0207). Exhaustion-associated markers were also increased, including lymphocyte activation gene-3 (LAG-3)+ and T cell Ig and mucin-domain-containing protein 3 (Tim-3)+ CD4+ T cells (P < 0.0411). CD8+ T cells mirrored these findings, with a six-fold increase in CD25 and doubled killer cell lectin-like receptor G1 (KLRG1) expression, accompanied by augmented IL-17A and IFN-γ/IL-17A production and antigen-specific proliferation (P < 0.0379). Expression of exhaustion-associated markers Tim-3+ and LAG-3+ on CD8+ T cells was likewise elevated (P < 0.0205). CONCLUSION: HomoCitP elicited Th1/Th17 and Tc1/Tc17 responses marked by concurrent expression of activation and exhaustion-associated markers, consistent with a dysregulated state. These findings position homocitrulline-driven CD4+ and CD8+ T cell imbalance as a potential mechanistic contributor to RA pathogenesis and a target for future immunomodulatory therapies.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Ulanova S, Kaur J, Buckley G, et al. Homocitrullinated Peptides Drive Pro-Inflammatory T Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis. Arthritis Rheumatol. 2026. PMID: 42257519. doi:10.1002/art.70239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。